Pazopanib diminishes non-small cell lung cancer (NSCLC) growth and metastases in vivo

BACKGROUND: Anti-angiogenesis has been demonstrated to have a critical role in lung cancer pathogenesis. Here, we characterized the effect of the small-molecule angiogenesis inhibitor pazopanib on non-small cell lung cancer (NSCLC) cells. METHODS: NSCLC cells were tested for viability and migration...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Honglin, Yang, Fan, Shen, Wang, Wang, Yuli, Li, Xuebing, You, Jiacong, Zhou, Qinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448486/
https://www.ncbi.nlm.nih.gov/pubmed/26273349
http://dx.doi.org/10.1111/1759-7714.12138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448486/
https://www.ncbi.nlm.nih.gov/pubmed/26273349
http://dx.doi.org/10.1111/1759-7714.12138

Ejemplares similares